Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 13

Zeitschriftenartikel

Heublein, Sabine; Mayr, Doris; Friese, Klaus; Jarrin-Franco, Maria Cristina; Lenhard, Miriam; Mayerhofer, Artur und Jeschke, Udo (September 2014): The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors. In: International Journal of Molecular Sciences, Bd. 15, Nr. 9: S. 15161-15172 [PDF, 1MB]

Lenhard, Miriam; Heublein, Sabine; Kunert-Keil, Christiane; Vrekoussis, Thomas; Lomba, Isabel; Ditsch, Nina; Mayr, Doris; Friese, Klaus und Jeschke, Udo (2013): Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer. In: BMC Cancer 13 [PDF, 2MB]

Heublein, Sabine; Grasse, Katinka; Hessel, Harald; Burges, Alexander; Lenhard, Miriam; Engel, Jutta; Kirchner, Thomas; Jeschke, Udo und Mayr, Doris (2013): KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants. In: BMC Cancer 13:483 [PDF, 1MB]

Heublein, Sabine; Vrekoussis, Thomas; Mayr, Doris; Friese, Klaus; Lenhard, Miriam; Jeschke, Udo und Dian, Darius (2013): Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR). In: Journal of Ovarian Research 6:6 [PDF, 1MB]

Ditsch, Nina; Toth, Bettina; Mayr, Doris; Lenhard, Miriam; Gallwas, Julia; Weissenbacher, Tobias; Dannecker, Christian; Friese, Klaus und Jeschke, Udo (2012): The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer. In: Journal of Histochemistry & Cytochemistry, Bd. 60, Nr. 2: S. 121-129 [PDF, 1MB]

Hertlein, Linda; Stieber, Petra; Kirschenhofer, Angela; Fürst, Sophie; Mayr, Doris; Hofmann, Karin; Krocker, Katja; Nagel, Dorothea; Lenhard, Miriam und Burges, Alexander (2012): Human epididymis protein 4 (HE4) in benign and malignant diseases. In: Clinical Chemistry and Laboratory Medicine, Bd. 50, Nr. 12: S. 2181-2188 [PDF, 216kB]

Engelstaedter, Verena; Heublein, Sabine; Schumacher, Anamur Lan; Lenhard, Miriam; Engelstaedter, Helen; Andergassen, Ulrich; Guenthner-Biller, Margit; Kuhn, Christina; Rack, Brigitte; Kupka, Markus; Mayr, Doris und Jeschke, Udo (2012): Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients. In: BMC Cancer 12:600 [PDF, 2MB]

Lenhard, Miriam; Tereza, Lennerova; Heublein, Sabine; Ditsch, Nina; Himsl, Isabelle; Mayr, Doris; Friese, Klaus und Jeschke, Udo (2012): Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival. In: BMC Cancer 12:553 [PDF, 1MB]

Lenhard, Miriam; Tsvilina, Alexandra; Schumacher, Lan; Kupka, Markus; Ditsch, Nina; Mayr, Doris; Friese, Klaus und Jeschke, Udo (2012): Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. In: BMC Cancer 12:2 [PDF, 1MB]

Scholz, Christoph; Heublein, Sabine; Lenhard, Miriam; Friese, Klaus; Mayr, Doris und Jeschke, Udo (2012): Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients. In: BMC Research Notes 5:551 [PDF, 2MB]

Lenhard, Miriam; Stieber, Petra; Hertlein, Linda; Kirschenhofer, Angela; Fuerst, Sophie; Mayr, Doris; Nagel, Dorothea; Hofmann, Karin; Krocker, Katja und Burges, Alexander (2011): The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. In: Clinical Chemistry and Laboratory Medicine, Bd. 49, Nr. 12: S. 2081-2088 [PDF, 368kB]

Lenhard, Miriam; Kuemper, Caroline; Ditsch, Nina; Diebold, Joachim; Stieber, Petra; Friese, Klaus und Burges, Alexander (2007): Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell turnours. In: Clinical Chemistry and Laboratory Medicine, Bd. 45, Nr. 5: S. 657-661 [PDF, 332kB]

Ditsch, Nina; Rückert, Sandra; Kümper, Carolin; Lenhard, Miriam; Kahlert, Steffen; Bauerfeind, Ingo; Friese, Klaus und Untch, Michael (2006): Trastuzumab (Herceptin (R)): Monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation. In: Breast Care, Nr. 2: S. 78-84 [PDF, 94kB]

Diese Liste wurde am Sun Mar 24 00:46:55 2024 CET erstellt.